These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin. Fujimoto Z; Fujii Y; Kaneko S; Kobayashi H; Mizuno H J Mol Biol; 2004 Aug; 341(5):1227-35. PubMed ID: 15321718 [TBL] [Abstract][Full Text] [Related]
25. Changes in proteinase/proteinase inhibitor levels in rat skeletal muscle tissue during diabetes and fasting. Kuehn L; Dahlmann B; Heath R; Kay J Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():299-305. PubMed ID: 3060141 [TBL] [Abstract][Full Text] [Related]
26. The many faces of protease-protein inhibitor interaction. Otlewski J; Jelen F; Zakrzewska M; Oleksy A EMBO J; 2005 Apr; 24(7):1303-10. PubMed ID: 15775973 [TBL] [Abstract][Full Text] [Related]
27. Structure of the carboxypeptidase Y inhibitor IC in complex with the cognate proteinase reveals a novel mode of the proteinase-protein inhibitor interaction. Mima J; Hayashida M; Fujii T; Narita Y; Hayashi R; Ueda M; Hata Y J Mol Biol; 2005 Mar; 346(5):1323-34. PubMed ID: 15713484 [TBL] [Abstract][Full Text] [Related]
28. Compromise and accommodation in ecotin, a dimeric macromolecular inhibitor of serine proteases. Gillmor SA; Takeuchi T; Yang SQ; Craik CS; Fletterick RJ J Mol Biol; 2000 Jun; 299(4):993-1003. PubMed ID: 10843853 [TBL] [Abstract][Full Text] [Related]
29. [Creation of synthetic serine proteinase inhibitors, an important pharmacological problem]. Markwardt F Farmakol Toksikol; 1978; 41(5):530-3. PubMed ID: 359347 [No Abstract] [Full Text] [Related]
30. [Mechanism of action of aspartyl proteinases. VI. Nonvalent enzyme-inhibitory and enzyme-substrate complexes of the aspartyl proteinase rhizopus pepsin]. Kashparov IV; Popov ME; Rumsh LD; Popov EM Bioorg Khim; 1999 Oct; 25(10):747-62. PubMed ID: 10645478 [TBL] [Abstract][Full Text] [Related]
31. Modeling studies of the change in conformation required for cleavage of limited proteolytic sites. Hubbard SJ; Eisenmenger F; Thornton JM Protein Sci; 1994 May; 3(5):757-68. PubMed ID: 7520312 [TBL] [Abstract][Full Text] [Related]
33. MEROPS: the peptidase database. Rawlings ND; Tolle DP; Barrett AJ Nucleic Acids Res; 2004 Jan; 32(Database issue):D160-4. PubMed ID: 14681384 [TBL] [Abstract][Full Text] [Related]
34. Natural protein proteinase inhibitors and their interaction with proteinases. Bode W; Huber R Eur J Biochem; 1992 Mar; 204(2):433-51. PubMed ID: 1541261 [TBL] [Abstract][Full Text] [Related]
35. Evidence of cell-associated proteinases from Virgibacillus sp. SK33 isolated from fish sauce fermentation. Sinsuwan S; Rodtong S; Yongsawatdigul J J Food Sci; 2011 Apr; 76(3):C413-9. PubMed ID: 21535808 [TBL] [Abstract][Full Text] [Related]
36. Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors. Rawlings ND; Barrett AJ; Finn R Nucleic Acids Res; 2016 Jan; 44(D1):D343-50. PubMed ID: 26527717 [TBL] [Abstract][Full Text] [Related]
37. Rapid refinement of protein interfaces incorporating solvation: application to the docking problem. Jackson RM; Gabb HA; Sternberg MJ J Mol Biol; 1998 Feb; 276(1):265-85. PubMed ID: 9514726 [TBL] [Abstract][Full Text] [Related]
39. The remarkable efficiency of a Pin-II proteinase inhibitor sans two conserved disulfide bonds is due to enhanced flexibility and hydrogen bond density in the reactive site loop. Joshi RS; Mishra M; Tamhane VA; Ghosh A; Sonavane U; Suresh CG; Joshi R; Gupta VS; Giri AP J Biomol Struct Dyn; 2014; 32(1):13-26. PubMed ID: 23256852 [TBL] [Abstract][Full Text] [Related]
40. Interactions between a viral protease and cystatins. Korant B; Towatari T; Kelley M; Brzin J; Lenarcic B; Turk V Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():281-6. PubMed ID: 3060140 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]